Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Mar;18(3):153-154.
doi: 10.1038/s41569-020-00502-3.

The neuropsychology of statin intolerance

Jennifer G Robinson  1
Affiliations
Comment

The neuropsychology of statin intolerance

Jennifer G Robinson. Nat Rev Cardiol. 2021 Mar.
No abstract available

PubMed Disclaimer

Comment on

  • N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects.
    Wood FA, Howard JP, Finegold JA, Nowbar AN, Thompson DM, Arnold AD, Rajkumar CA, Connolly S, Cegla J, Stride C, Sever P, Norton C, Thom SAM, Shun-Shin MJ, Francis DP. Wood FA, et al. N Engl J Med. 2020 Nov 26;383(22):2182-2184. doi: 10.1056/NEJMc2031173. Epub 2020 Nov 15. N Engl J Med. 2020. PMID: 33196154 Clinical Trial. No abstract available.

References

    1. Bradley, C. et al. Patient reported reasons for declining or discontinuing statin therapy: insights from the PALM registry. J. Am. Heart Assoc. 8, e011765 (2019). - PubMed - PMC
    1. Ganga, H. V., Slim, H. B. & Thompson, P. D. A systematic review of statin-induced muscle problems in clinical trials. Am. Heart J. 168, 6–15 (2014). - DOI
    1. Moriarty, P. M. et al. Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: the ODYSSEY ALTERNATIVE randomized trial. J. Clin. Lipidol. 9, 758–769 (2015). - DOI
    1. Wood, F. A. et al. N-of-1 trial of a statin, placebo, or no treatment to assess side effects. N. Engl. J. Med. https://doi.org/10.1056/NEJMc2031173 (2020). - DOI - PubMed - PMC
    1. Robinson, J. G. New insights into managing symptoms during statin therapy. Prog. Cardiovasc. Dis. 62, 390–394 (2019). - DOI

MeSH terms

Substances

LinkOut - more resources